Janus Henderson Global Life Sciences Fund Class T (JAGLX) verð á verðbréfasjóðum og fréttir – Google Finance

Fjármál

HeimJAGLX • Verðbréfasjóður

Janus Henderson Global Life Sciences Fund Class T

80,44 $

31. des. · USD · MUTF · Lagalegir fyrirvarar

BlackRock Health Sciences Opportunities Portfolio Investor A Shares

64,73 $

SHSAX0,42%

Franklin Biotechnology Discovery Fund Class A

165,74 $

FBDIX0,41%

Fidelity Select Health Care Portfolio

28,43 $

FSPHX0,18%

ProFunds Biotechnology UltraSector Fund Investor Class

67,30 $

BIPIX0,27%

Fidelity Advisor Biotechnology Fund - Class A

37,44 $

FBTAX0,11%

Vanguard Health Care Fund Admiral Shares

86,25 $

VGHAX0,37%

Janus Henderson Contrarian Fund Class D

26,82 $

JACNX0,81%

ProFunds UltraNASDAQ-100 Fund Investor Class

125,40 $

UOPIX1,68%

Rydex NASDAQ-100® 2x Strategy Fund Class C

449,63 $

RYCCX1,71%

Fidelity Advisor Blue Chip Growth Fund - Class A

265,68 $

FBCCX0,70%

Verðbréfasjóður

Við síðustu lokun

80,68 $

Ávöxtun á árinu

24,87%

Kostnaðarhlutfall

0,92%

Flokkur

Healthcare Sector Equity

Morningstar-einkunn

Hrein eign

1,32 ma. USD

Ávöxtun

0,17%

Söluþóknun

-

Upphafsdagur

31. des. 1998

Viðskiptafréttir

Canadian stocks set records in 'jaw-dropping' year

S&P/TSX composite down more than 70 points, US stock markets in negative territory

Yahoo! Finance Canada

2 of the Best TSX Stocks to Buy Before They Start to Recover

S&P/TSX composite finishes lower to end the year, U.S. markets also slide

The Motley Fool Canada

3 TSX Stocks That Could Triple in 5 Years

The Globe and Mail

The TSX just had its biggest annual gain in over 15 years. Don’t expect a repeat

Leit

Hreinsa leit

Loka leit

Google forrit

Aðalvalmynd